Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

Abstract PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 blockade therapy has been trialed in a broad range of malignancies and achieved clinical success. Despite the potentially...

Full description

Bibliographic Details
Main Authors: Jin-Yu Sun, Dengke Zhang, Songquan Wu, Min Xu, Xiao Zhou, Xiao-Jie Lu, Jiansong Ji
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Biomarker Research
Subjects:
PD-1/PD-L1 blockade
Cancer immunotherapy
Resistance
Online Access:http://link.springer.com/article/10.1186/s40364-020-00212-5

Internet

http://link.springer.com/article/10.1186/s40364-020-00212-5

Similar Items